Related Experiment Video

Updated: Jun 25, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells

Takefumi Inada1, Kozue Kubo, Tomoko Kambara

  • 1Department of Anesthesiology, Kansai Medical University, 10-15, Fumizono-cho, Moriguchi, Osaka 570-8507, Japan. nvkc20988@hera.eonet.ne.jp

Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|February 28, 2009
PubMed
Abstract

Insights

Propofol significantly reduces prostanoid production by inhibiting cyclooxygenase activity in immune cells. This suppression of prostaglandin E2 and thromboxane B2 may enhance immune responses and modulate inflammation.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Monocytes/macrophages are crucial for immune responses.
  • Upon stimulation, they produce prostanoids (like prostaglandin E2 and thromboxane B2) via cyclooxygenase (COX) activity.
  • Prostanoids play a significant role in regulating inflammation and immune cell function.

Purpose of the Study:

  • To investigate the impact of propofol on prostaglandin E2 (PGE2) and thromboxane B2 (TXB2) production.
  • To determine if propofol affects cyclooxygenase (COX) activity or protein expression in human monocytic cells.

Main Methods:

  • Human monocytic THP-1 cells were stimulated with lipopolysaccharide (LPS).
  • Cells were treated with varying concentrations of propofol (0-30 microM).
  • Prostanoid production, COX protein expression, and COX activity were measured.

Main Results:

  • Propofol significantly decreased PGE2 and TXB2 production in a dose-dependent manner.
  • The reduction in prostanoids was not due to altered COX protein expression.
  • Propofol directly suppressed COX activity, as evidenced by reduced prostanoid synthesis after arachidonic acid substrate addition.

Conclusions:

  • Propofol suppresses cyclooxygenase activity, thereby reducing prostanoid production.
  • This mechanism suggests propofol may modulate inflammation and potentially enhance immune responses.

More Related Videos

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells06:55

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

Published on: October 19, 2021

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!